Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.

Takeyuki Hiramatsu,Hiroki Ito,Shota Okumura,Yuko Asano,Daiki Iguchi,Shinji Furuta

Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.

2020

Takeyuki Hiramatsu
Hiroki Ito
Shota Okumura
Yuko Asano
Daiki Iguchi
Shinji Furuta

Introduction:Diabetes mellitus is a progressive disease with cardiovascular complications. We evaluated the impact of a glucagon like peptide-1 (GLP-1) receptor agonist and sodium glucose cotranspo...

Keywords:

Receptor
Type 2 diabetes
Agonist
Internal medicine
Glucagon-like peptide 1 receptor
Glucagon
Sodium/Glucose Cotransporter 2
Medicine
Diabetes mellitus
Endocrinology
Albuminuria

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations